Neophyr (Nitric Oxide)

Nitric Oxide, the active ingredient in Neophyr, is a vasodilator presented as a medical gas for inhalation use. It acts on the pulmonary vasculature to reduce pressure and improve oxygenation, and is employed in clinical settings for conditions such as persistent pulmonary hypertension of the newborn, acute respiratory distress syndrome, and other forms of pulmonary hypertension.

GNH USA supplies Neophyr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, and specialty clinics worldwide, with a focus on quality assurance and regulatory compliance.

Neophyr (inhaled nitric oxide) is used in the management of pulmonary vascular disorders and related respiratory conditions. - Persistent Pulmonary Hypertension of the Newborn (PPHN): improves oxygenation by selectively dilating pulmonary vessels. - Acute Respiratory Distress Syndrome (ARDS): reduces pulmonary arterial pressure and enhances gas exchange. - Pulmonary Hypertension in adults: serves as a short‑term adjunct to lower pulmonary artery pressure during critical care.

Inhaled nitric oxide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient. - Flushing: skin warmth and redness. - Cough: irritation of airway.

Serious or Rare Side Effects: - Severe methemoglobinemia: high methemoglobin causing hypoxia. - Rebound pulmonary hypertension: worsening pressure after abrupt discontinuation. - Bleeding: due to platelet inhibition.

When using Neophyr, careful monitoring and specific safety measures are essential. - Patient selection: use only in settings with appropriate monitoring of oxygenation and hemodynamics. - Methemoglobin monitoring: regularly assess methemoglobin levels during therapy. - Dose titration: adjust concentration based on clinical response and arterial blood gases. - Interaction with hemoglobin: avoid in patients with G6PD deficiency or significant anemia. - Discontinuation: taper gradually to prevent rebound pulmonary hypertension. - Store at ambient temperature: keep cylinders in original packaging, protect from heat and direct sunlight.

Inhaled nitric oxide can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Phosphodiesterase inhibitors (e.g., sildenafil): additive pulmonary vasodilation may cause severe hypotension. - Inhaled anesthetics (e.g., nitrous oxide): can potentiate methemoglobinemia.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., heparin): increased risk of bleeding. - Other vasodilators (e.g., prostacyclin analogues): may enhance hypotensive effects. - Hemoglobin modifiers (e.g., methylene blue): may interfere with methemoglobin reduction.